Coherus amends office lease, reduces space 42%, extends term to 2027

Coherus Oncology, Inc.

Lease reduced from ~47,789 sq ft to ~27,532 sq ft; 20,257 sq ft expire Dec 31, 2023.
Remaining premises lease extended through Sep 30, 2027.
Monthly base rent ~$0.17M from Jan-Sep 2024; annual rent ~$1.77M rising to ~$1.88M.
Limited rent abatements on remaining premises before Sep 30, 2024.

item 1.01 item 2.03

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Coherus Oncology, Inc. amended Sixth Amendment with Hudson 333 Twin Dolphin Plaza, LLC (effective 2023-10-24).

Action: amendment
Agreement: lease
Counterparty: Hudson 333 Twin Dolphin Plaza, LLC
Effective: 2023-10-24

Exact text from the filing

(the “Company”) has been a party to an existing Office Lease (as amended, the “Lease”) with Hudson 333 Twin Dolphin Plaza, LLC (the “Landlord”), under which the Company leases approximately 47,789 square feet of office space located at 333 Twin Dolphin Drive, Redwood City, California (the “Currently Existing Premises”) for the Company’s principal executive offices with an expiration date of September 30, 2024 (the “Extended Expiration Date”).

View on SEC.gov

242 material agreements filed in the last 30 days. Browse all material agreements →

Coherus Oncology, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-23-016946

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.